Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the overall safety of Lapaquistat Acetate, once
daily (QD), by itself or in combination with atorvastatin in subjects with primary
dyslipidemia.